Table 2.
Summary of outcomes by group. Reported as n (%) or mean ± standard deviation. No significant group differences were observed for any of these outcome parameters
| Outcome parameter | Group | P | |
|---|---|---|---|
| H‐Mis (n = 250) | S‐Mis (n = 283) | ||
| Discharged conceptus | |||
| 1–6 h after misoprostol | 232 (92.8%) | 252 (89.0%) | 0.389 |
| Greater than 6 h after misoprostol | 18 (7.2%) | 31 (11.0%) | 0.292 |
| Discharged gestational tissue | 39 (15.6%) | 46 (16.3%) | 0.733 |
| Days of bleeding | 8.91 ± 2.34 | 9.11 ± 1.89 | 0.507 |
| Efficacy | |||
| Complete abortion (success rate) | 237 (94.8%) | 266 (94.0%) | 0.472 |
| Failure rate (total) | 13 (5.2%) | 17 (6.0%) | 0.878 |
| Incomplete abortion | 7 (2.8%) | 10 (3.5%) | 0.639 |
| Ongoing pregnancy | 6 (2.4%) | 7 (2.5%) | 0.231 |
| Unscheduled reattendance | 55 (22.0%) | 61 (21.6%) | 00.100 |
| Incomplete abortion (suspicious/confirmed) | 18/7 | 21/10 | 0.355 |
| Ongoing pregnancy (suspicious/confirmed) | 19/6 | 17/7 | 0.230 |
| Ectopic pregnancy (suspicious/confirmed) | 3/0 | 2/0 | 0.658 |
| Participant preference | 15 | 21 | 0.453 |
| Adverse effects | |||
| Nausea | 99 (39.6%) | 121 (42.8%) | 0.537 |
| Vomiting | 18 (7.2%) | 21 (7.4%) | 0.768 |
| Abdominal pain | 178 (71.2%) | 212 (74.9%) | 0.255 |
| Dizziness | 37 (14.8%) | 29 (10.2%) | 0.401 |
| Headache | 23 (9.2%) | 19 (6.7%) | 0.298 |
| Satisfaction | |||
| Satisfactory overall | 231 (92.4%) | 263 (92.9%) | 0.376 |
| Convenient administration | 211 (84.4%) | 270 (95.4%) | 0.048 |
| Satisfactory privacy protection | 214 (85.6%) | 267 (94.3%) | 0.057 |
| Concerns about continued pregnancy and safety | 19 (7.6%) | 20 (7.1%) | 0.346 |